Product image
InVivoMAb anti-human/rat HER2 (neu)
BE0277
ApplicationsFlow Cytometry, ImmunoFluorescence, ImmunoPrecipitation, Other Application
Product group Antibodies
ReactivityHuman, Rat
Overview
- SupplierBio X Cell
- Product NameInVivoMAb anti-human/rat HER2 (neu)
- Delivery Days Customer7
- ApplicationsFlow Cytometry, ImmunoFluorescence, ImmunoPrecipitation, Other Application
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone ID7.16.4
- Concentration4-11 mg/ml
- Estimated Purity>95%
- HostMouse
- IsotypeIgG2a
- ReactivityHuman, Rat
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- Sequential Anti-PD1 Therapy Following Dendritic Cell Vaccination Improves Survival in a HER2 Mammary Carcinoma Model and Identifies a Critical Role for CD4 T Cells in Mediating the Response. Kodumudi KN et al., 2019, Front ImmunolRead more
- Single-cell profiling guided combinatorial immunotherapy for fast-evolving CDK4/6 inhibitor-resistant HER2-positive breast cancer. Wang Q et al., 2019 Aug 23, Nat CommunRead more
- The therapeutic effect of anti-HER2/neu antibody depends on both innate and adaptive immunity. Park S et al., 2010 Aug 9, Cancer CellRead more
- Neu antigen-negative variants can be generated after neu-specific antibody therapy in neu transgenic mice. Knutson KL et al., 2004 Feb 1, Cancer ResRead more
- Shared antigenic epitopes and pathobiological functions of anti-p185(her2/neu) monoclonal antibodies. Zhang H et al., 1999 Sep, Exp Mol PatholRead more
- Monoclonal antibodies identify a cell-surface antigen associated with an activated cellular oncogene. Drebin JA et al., 1984 Dec 6-12, NatureRead more
- Inhibition of tumor growth by a monoclonal antibody reactive with an oncogene-encoded tumor antigen. Drebin JA et al., 1986 Dec, Proc Natl Acad Sci U S ARead more